Allegra-d Allergy And Congestion Tablet, Film Coated, Extended Release
Product Images NDC 41167-4320

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Allegra-d Allergy And Congestion (NDC 41167-4320). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chattem, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panelndc 41167-4320-7non-drowsyallegra-d®allergy & Congestionfexofenadine HCl 180 mg/antihistaminepseudoephedrine HCl 240 mg/nasal Decongestantextended Release Tablets15 Tablets (Allegra D Allergy And Congestion 24 Hr 01)

Packaging label for Allegra-D Allergy & Congestion 24 HR extended-release tablets. The product contains fexofenadine HCl 180 mg antihistamine and pseudoephedrine HCl 240 mg nasal decongestant. The label indicates 15 tablets in the package, manufactured by Chattem, Inc. The design features a purple and orange color scheme with clear identification of non-drowsy relief for indoor/outdoor allergy and congestion symptoms.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.